Terms: = Breast cancer AND uPA AND Treatment
205 results:
1. Synergy between PEDF and Doxorubicin in breast cancer Cells: Effects on Metastatic and Metabolic Pathways.
Abooshahab R; Al-Salami H; Dass CR
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474001
[TBL] [Abstract] [Full Text] [Related]
2. Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.
Wimmer K; Sachet M; Ramos C; Frantal S; Birnleitner H; Brostjan C; Exner R; Filipits M; Bago-Horvath Z; Rudas M; Bartsch R; Gnant M; Singer CF; Balic M; Egle D; Oehler R; Fitzal F
J Exp Clin Cancer Res; 2023 Nov; 42(1):300. PubMed ID: 37957750
[TBL] [Abstract] [Full Text] [Related]
3. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase-Human Serum Albumin Improves the treatment Outcome of Triple-Negative breast cancer Therapy.
Zhou Y; Yu S; Chen D; Li H; Xu P; Yuan C; Jiang L; Huang M
Mol Pharm; 2023 Feb; 20(2):905-917. PubMed ID: 36463525
[TBL] [Abstract] [Full Text] [Related]
4. Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis.
Demirtas Korkmaz F; Dogan Turacli I; Esendagli G; Ekmekci A
Mol Biol Rep; 2022 Nov; 49(11):10387-10397. PubMed ID: 36097108
[TBL] [Abstract] [Full Text] [Related]
5. Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects.
Miller IS; Khan S; Shiels LP; Das S; O' Farrell AC; Connor K; Lafferty A; Moran B; Isella C; Loadman P; Conroy E; Cohrs S; Schibli R; Kerbel RS; Gallagher WM; Marangoni E; Bennett K; O' Connor DP; Dwyer RM; Byrne AT
Cancer Med; 2022 Oct; 11(20):3820-3836. PubMed ID: 35434898
[TBL] [Abstract] [Full Text] [Related]
6. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
[TBL] [Abstract] [Full Text] [Related]
7. [upa/PAI-1 and EPClin®: Comparison of their impact on the management of intermediate-prognosis breast cancers].
Maniez P; Osada M; Reix N; Mathelin C
Gynecol Obstet Fertil Senol; 2022 Apr; 50(4):298-306. PubMed ID: 34626849
[TBL] [Abstract] [Full Text] [Related]
8. Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes.
Lee O; Bosland MC; Wang M; Shidfar A; Hosseini O; Xuei X; Patel P; Schipma MJ; Helenowski I; Kim JJ; Clare SE; Khan SA
Cancer Lett; 2021 Nov; 520():255-266. PubMed ID: 34329741
[TBL] [Abstract] [Full Text] [Related]
9. upa-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils.
Uhl B; A Mittmann L; Dominik J; Hennel R; Smiljanov B; Haring F; B Schaubächer J; Braun C; Padovan L; Pick R; Canis M; Schulz C; Mack M; Gutjahr E; Sinn P; Heil J; Steiger K; Kanse SM; Weichert W; Sperandio M; Lauber K; Krombach F; Reichel CA
EMBO Mol Med; 2021 Jun; 13(6):e13110. PubMed ID: 33998175
[TBL] [Abstract] [Full Text] [Related]
10. Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative breast cancer by Positron Emission Tomography.
Lu W; Cong Y; Yang D; Chen D; Yang G; Wang Y; Van Dort ME; Ross BD; Mazar AP; Chu BB; Hong H
Mol Pharm; 2021 Apr; 18(4):1690-1698. PubMed ID: 33734721
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic modulators combination with chemotherapy in breast cancer cells.
Ari F; Napieralski R; Akgun O; Magdolen V; Ulukaya E
Cell Biochem Funct; 2021 Jun; 39(4):571-583. PubMed ID: 33608886
[TBL] [Abstract] [Full Text] [Related]
12.
Mabasa R; Malemela K; Serala K; Kgakishe M; Matsebatlela T; Mokgotho M; Mbazima V
Integr Cancer Ther; 2021; 20():1534735420977684. PubMed ID: 33565349
[TBL] [Abstract] [Full Text] [Related]
13. Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.
Rajendran P; Ben Ammar R; Al-Saeedi FJ; Elsayed Mohamed M; Islam M; Al-Ramadan SY
J Cell Mol Med; 2020 Dec; 24(24):14525-14538. PubMed ID: 33159487
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer: Biology, biomarkers, and treatments.
Barzaman K; Karami J; Zarei Z; Hosseinzadeh A; Kazemi MH; Moradi-Kalbolandi S; Safari E; Farahmand L
Int Immunopharmacol; 2020 Jul; 84():106535. PubMed ID: 32361569
[TBL] [Abstract] [Full Text] [Related]
15. An Activatable Polymeric Reporter for Near-Infrared Fluorescent and Photoacoustic Imaging of Invasive cancer.
Li Q; Li S; He S; Chen W; Cheng P; Zhang Y; Miao Q; Pu K
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7018-7023. PubMed ID: 32124526
[TBL] [Abstract] [Full Text] [Related]
16. The anti-tumoral potential of the saporin-based upaR-targeting chimera ATF-SAP.
Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of TPA‑induced metastatic potential by morin hydrate in MCF‑7 human breast cancer cells via the Akt/GSK‑3β/c‑Fos signaling pathway.
Lee KS; Nam GS; Baek J; Kim S; Nam KS
Int J Oncol; 2020 Feb; 56(2):630-640. PubMed ID: 31939617
[TBL] [Abstract] [Full Text] [Related]
18. pH-Sensitive Shell-Core Platform Block DNA Repair Pathway To Amplify Irreversible DNA Damage of Triple Negative breast cancer.
Dong Y; Liao H; Fu H; Yu J; Guo Q; Wang Q; Duan Y
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38417-38428. PubMed ID: 31556584
[TBL] [Abstract] [Full Text] [Related]
19. A novel machine learning-derived decision tree including upa/PAI-1 for breast cancer care.
Reix N; Lodi M; Jankowski S; Molière S; Luporsi E; Leblanc S; Scheer L; Ibnouhsein I; Benabu JC; Gabriele V; Guggiola A; Lessinger JM; Chenard MP; Alpy F; Bellocq JP; Neuberger K; Tomasetto C; Mathelin C
Clin Chem Lab Med; 2019 May; 57(6):901-910. PubMed ID: 30838840
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic relevance of urokinase-type plasminogen activator (upa) in the blood of patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Aktas B; Fasching PA; Hartkopf A; Janni W; Kasimir-Bauer S; Pantel K; Schön G; Rack B; Riethdorf S; Solomayer EF; Fehm T; Müller V
Sci Rep; 2019 Feb; 9(1):2318. PubMed ID: 30783124
[TBL] [Abstract] [Full Text] [Related]
[Next]
